Stadnyk Meredith, Sevick Johnathan L, Wu Kezhou, Elliott Janet A W, Jomha Nadr M
Department of Surgery, University of Alberta, Edmonton, AB, Canada.
Department of Orthopedic Surgery, First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, China.
Cell Tissue Bank. 2022 Mar;23(1):31-41. doi: 10.1007/s10561-021-09906-y. Epub 2021 Feb 25.
Osteochondral allografts are often used to repair large articular cartilage defects to prevent or delay the onset of osteoarthritis. This approach is limited by the timely acquisition and use of allograft tissue since standard hypothermic protocols allow for a maximum storage of 4 weeks. Vitrification is a proven technique for the long-term preservation of cells and tissues, but requires careful determination of parameters to be successful, particularly for articular cartilage. One parameter that is infrequently considered is the choice of cryoprotectant vehicle solution. The aim of this study was to evaluate the impact of a subset of vehicle solutions on an established vitrification protocol for articular cartilage. These solutions were phosphate-buffered saline (PBS), Dulbecco's Modified Eagle's Medium: Nutrient Mixture F-12 (DMEM), X-VIVO, and Unisol-CV (UCV). Both the solution pH at various points throughout vitrification and the cell viability of porcine articular cartilage slices following vitrification were measured. Using randomized block ANOVA, it was found that the normalized cell viability of articular cartilage vitrified in UCV was significantly greater than that of PBS (p < 0.05) and may be greater than those of DMEM and X-VIVO (p < 0.1). There was no correlation between pH parameters and cell viability, although significant differences between calculated pH parameters were identified. These results provide information to guide the design of effective vitrification protocols for articular cartilage.
骨软骨异体移植常用于修复大面积关节软骨缺损,以预防或延缓骨关节炎的发生。由于标准低温保存方案允许的最长保存时间为4周,这种方法受到异体移植组织及时获取和使用的限制。玻璃化是一种已被证实的细胞和组织长期保存技术,但要取得成功需要仔细确定参数,特别是对于关节软骨。一个很少被考虑的参数是冷冻保护剂载体溶液的选择。本研究的目的是评估一组载体溶液对既定的关节软骨玻璃化方案的影响。这些溶液是磷酸盐缓冲盐水(PBS)、杜氏改良伊格尔培养基:营养混合物F-12(DMEM)、X-VIVO和Unisol-CV(UCV)。在整个玻璃化过程中的不同时间点测量溶液pH值,并在玻璃化后测量猪关节软骨切片的细胞活力。使用随机区组方差分析发现,在UCV中玻璃化的关节软骨的标准化细胞活力显著高于PBS(p<0.05),可能也高于DMEM和X-VIVO(p<0.1)。尽管计算出的pH参数之间存在显著差异,但pH参数与细胞活力之间没有相关性。这些结果为指导设计有效的关节软骨玻璃化方案提供了信息。